1234

ͻϮҽҩ | רʹάŷˮ˭ͬ


ͻϮҽҩ | רʹάŷˮ˭ͬ(ͼ2)


ͻϮҽҩ | רʹάŷˮ˭ͬ(ͼ5)


ͻϮҽҩ | רʹάŷˮ˭ͬ(ͼ7)


ͻϮҽҩ | רʹάŷˮ˭ͬ(ͼ12)


ͻϮҽҩ | רʹάŷˮ˭ͬ(ͼ14)


ͻϮҽҩ | רʹάŷˮ˭ͬ(ͼ16)

ԭ⣺ͻϮҽҩ | רʹάŷˮ˭ͬ

/ ന / Ԭ

ͻϮȫҩ۶аϣά˾֣ʪؽסǿֱԼ׵ȼռݰλѾã۶ڲӡǣfiercepharmaվһBernsteinķҩоƣ2019꽫Ƕ԰άսһ꣬ù˾šר¡ÿ180Ԫŷʧȥ˶ҾӪȨƷгѾ˷ҩù˾߹ܶ2020ŷʧ20%Ԥֹˡ

˽ʲôǡר¡зһִҩʱ䡢Ͷ붼dz󣬹ȥΪһҩɱԼ10ԪѾʮڡΪ˹ҩзҩطҩһʱ¢гԤۡǣҲΪһҩԶר¢ϣͲܴﵽԴŻ¢ڹзõݶԱʹãƵҩǷҩҩ۾ͱѹȫಡܹЧ档֪ҩЧƶ۸˵ҩԭҩ۶򽫱ֱ½·ӡ¡һ

BernsteinʦRonny GalܣŷַҩּСҩ201810ŷУͨһµݿɿͷʮǿ˰άܵijӦԤҪһЩҩռŷгݶҩImraldiAmgevita󡣴õĵ¹Ӣޡ˹άǵҲ𽥷仯Ԥҩڵһռ50%г

ά߹1µĵļ绰Ҳʾַҩ¹˾۶½20Ԫ˾³ϯִйRichard GonzalezԤ⣬2019뽫½26%27%ߵ30%ռ˾61%㣬26%Ĺ˾ʧζҩŷ޵40%

Galıָͬר£ٰ͡ҩķҩŷ7£ʴﵽ14%ȸù˾޻ǻܰȰ֢ҩгתٶȸ죬ټϰ˹ٰ͡ҩҾӪȨɥʧ˾ۼƶ½200Ԫķա

2018ȣ޻ŷ޵۶½49%2.07ԪFDA׼Celltrion˾ķҩTruximaϵרԽԽȻϯִйDaniel ODayΪ۶ʧŷô죬ҲܶҩƷȡκжܼٷҩ

ٽTecfideraĺĬҩר¿ǰ굽רֽ̱ר飬2020ҩ201842.7Ԫ룬ҩͷӮרȨٽʮԪʧ

Galָҩȷʵŷܵӭ磬ǿˣʪؽ׵ȼҩռг6%гͬʱҲһҩ۸ͬʱ½˼۸ͬ½10.7 %֮£ҩInflectraļ۸½24.2 %Ĭ˷ҩRenflexisļ۸½18 %гڷʹ÷ҩ籣չ˾ͻܵģҪʹһҩķҩôҽʦͻתΪûʹһָԭҩ

Ȼ״ҲǿԱƵġȥ10£ҽƱպҽƲĵ¹涨ƶ£HealthcareҽƱռƻǵһЩƼˡƷҪҽʦڿʼʱʹһЩͼҩŲĽչʹðĸ߼ҩɴˣҵҲԲƵIJƶҩIJá

磬׼˷Ǹ˾̼ͤϸҩķҩFulphila˲Ʒռ4%г˷ҩռ6%ٶȣѾܲˡ

οϣ

http://www.fiercepharma.com/pharma/humira-biosimilars-catch-fire-europe-and-could-take-half-market-a-year-report

http://www.fiercepharma.com/pharma/biogen-faces-new-patent-threat-from-mylan-blockbuster-tecfidera

ĶƼ:

ͼ

Ҷڿ

ܸȤ